Literature DB >> 17683826

Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Jaspreet K Vasir1, Vinod Labhasetwar.   

Abstract

Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment. To achieve efficient cytosolic delivery of therapeutics, different nanomaterials have been developed that consider the diverse physicochemical nature of therapeutics (macromolecule to small molecule; water soluble to water insoluble) and various membrane associated and intracellular barriers that these systems need to overcome to efficiently deliver and retain therapeutics in the cytoplasmic compartment. Our interest is in investigating PLGA and PLA-based nanoparticles for intracellular delivery of drugs and genes. The present review discusses the various aspects of our studies and emphasizes the need for understanding of the molecular mechanisms of intracellular trafficking of nanoparticles in order to develop an efficient cytosolic delivery system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683826      PMCID: PMC2002520          DOI: 10.1016/j.addr.2007.06.003

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  72 in total

1.  Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.

Authors:  Mary Jo Turk; Joseph A Reddy; Jean A Chmielewski; Philip S Low
Journal:  Biochim Biophys Acta       Date:  2002-02-10

2.  pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules.

Authors:  R M Straubinger; N Düzgünes; D Papahadjopoulos
Journal:  FEBS Lett       Date:  1985-01-01       Impact factor: 4.124

3.  Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes.

Authors:  A J Schroit; J Madsen; R Nayar
Journal:  Chem Phys Lipids       Date:  1986 Jun-Jul       Impact factor: 3.329

4.  A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.

Authors:  M Tobío; J Nolley; Y Guo; J McIver; M J Alonso
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

5.  pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact.

Authors:  H Ellens; J Bentz; F C Szoka
Journal:  Biochemistry       Date:  1984-03-27       Impact factor: 3.162

6.  Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: a rational gene therapy for primary hyperoxaluria-1 (PH-1).

Authors:  Sweaty Koul; Thomas Johnson; Saroj Pramanik; Hari Koul
Journal:  Am J Nephrol       Date:  2005-04-21       Impact factor: 3.754

7.  Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins.

Authors:  Enrico Mastrobattista; Gerben A Koning; Louis van Bloois; Ana C S Filipe; Wim Jiskoot; Gert Storm
Journal:  J Biol Chem       Date:  2002-05-20       Impact factor: 5.157

8.  Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin.

Authors:  Chester J Provoda; Ethan M Stier; Kyung-Dall Lee
Journal:  J Biol Chem       Date:  2003-06-27       Impact factor: 5.157

9.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.

Authors:  E Wagner; C Plank; K Zatloukal; M Cotten; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

10.  Critical determinants in PLGA/PLA nanoparticle-mediated gene expression.

Authors:  Swayam Prabha; Vinod Labhasetwar
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more
  107 in total

1.  Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.

Authors:  Yoon Ki Joung; Sejin Son; Ji Young Jang; Myung Hee Kwon; Ki Dong Park
Journal:  Pharm Res       Date:  2011-12-03       Impact factor: 4.200

2.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

Review 3.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

4.  Utility of biodegradable plasmonic nanoclusters in photoacoustic imaging.

Authors:  Soon Joon Yoon; Srivalleesha Mallidi; Jasmine M Tam; Justina O Tam; Avinash Murthy; Keith P Johnston; Konstantin V Sokolov; Stanislav Y Emelianov
Journal:  Opt Lett       Date:  2010-11-15       Impact factor: 3.776

Review 5.  Peptide/protein vaccine delivery system based on PLGA particles.

Authors:  Mojgan Allahyari; Elham Mohit
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 6.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

7.  A PEG-Fmoc conjugate as a nanocarrier for paclitaxel.

Authors:  Peng Zhang; Yixian Huang; Hao Liu; Rebecca T Marquez; Jianqin Lu; Wenchen Zhao; Xiaolan Zhang; Xiang Gao; Jiang Li; Raman Venkataramanan; Liang Xu; Song Li
Journal:  Biomaterials       Date:  2014-05-22       Impact factor: 12.479

Review 8.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Authors:  Yunching Chen; Dong-Yu Gao; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2014-05-22       Impact factor: 15.470

9.  The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.

Authors:  Malgorzata S Cartiera; Katherine M Johnson; Vanathy Rajendran; Michael J Caplan; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-02-20       Impact factor: 12.479

Review 10.  Intracellular Delivery of Trehalose for Cell Banking.

Authors:  Samantha Stewart; Xiaoming He
Journal:  Langmuir       Date:  2018-08-20       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.